Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
12.46
-5.48 (-30.54%)
At close: Apr 28, 2026, 4:00 PM EDT
13.57
+1.12 (8.95%)
After-hours: Apr 28, 2026, 7:58 PM EDT
Cue Biopharma Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$120.00
Upside
+863.47%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LUCID CAPITAL MARKETS | LUCID CAPITAL MARKETS | Strong Buy Initiates $120 | Strong Buy | Initiates | $120 | +863.47% | Aug 25, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $60 | Buy | Reiterates | $60 | +381.73% | Apr 2, 2025 |
| Stifel | Stifel | Strong Buy Maintains $240 → $120 | Strong Buy | Maintains | $240 → $120 | +863.47% | Aug 20, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $450 → $60 | Buy | Maintains | $450 → $60 | +381.73% | Jul 26, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $240 → $90 | Buy | Maintains | $240 → $90 | +622.60% | Jul 26, 2024 |
| Stifel | Stifel | Strong Buy Maintains $240 | Strong Buy | Maintains | $240 | +1,826.94% | Apr 9, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $300 | Buy | Maintains | $300 | +2,308.67% | Apr 9, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $240 | Buy | Reiterates | $240 | +1,826.94% | Apr 3, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $180 | Strong Buy | Initiates | $180 | +1,345.20% | Mar 13, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $210 → $240 | Buy | Maintains | $210 → $240 | +1,826.94% | Nov 6, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $300 | Buy | Initiates | $300 | +2,308.67% | Jun 26, 2023 |
| Stifel | Stifel | Strong Buy Reiterates $240 | Strong Buy | Reiterates | $240 | +1,826.94% | Jun 15, 2023 |
| JMP Securities | JMP Securities | Buy Reiterates $450 | Buy | Reiterates | $450 | +3,513.01% | May 15, 2023 |
| Stifel | Stifel | Strong Buy Maintains $270 → $240 | Strong Buy | Maintains | $270 → $240 | +1,826.94% | Mar 22, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $300 | Buy | Reiterates | $300 | +2,308.67% | Mar 22, 2023 |
| Piper Sandler | Piper Sandler | Buy Initiates $210 | Buy | Initiates | $210 | +1,586.07% | Nov 21, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.